EUVIMEDOpdag EUVIMED
Crossref

Efficacy and safety of platelet additive solution‐E stored platelet concentrates

Saskia E Spelmink iD, Suzanne T Jager, Leo van de Watering iD, Pieter F van der Meer, Adriaan J van Gammeren iD, Johanna C Wiersum-Osselton, Thomas R L Klei, Jean-Louis H Kerkhoffs, PAS-E Research group

Transfusion · 2023

DOI: 10.1111/trf.17583 ↗

At a glance

Journal article in Transfusion, 2023. Written by Saskia E Spelmink and 8 co-authors. Institution: Department of Transfusion Medicine, Sanquin Blood Bank, Amsterdam, The Netherlands. Major MEDLINE topics: Transfusion Reaction, Hypersensitivity. Cited 9 times so far (Crossref); 10 references. Funded by: Terumo BCT.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

In 2018, platelet (PLT) additive solution‐E (PAS‐E) was introduced. The implementation of PAS‐E was expected to diminish the number of allergic reactions in recipients following a PLT transfusion. Here, we evaluated the efficacy and safety of transfusions with PLTs stored in PAS‐E. Study Design and Methods After implementation of PAS‐E, data were collected from 2 cohorts of patients with hematological disorders as well as oncology patients, receiving PLTs in PAS‐E. A similar patient group in a recent RCT, receiving PLTs in plasma, was used as a historical control group for both cohorts. Endpoints were corrected count increments (CCIs), bleeding scores (only reported in cohort 1), and the incidence of adverse reactions.

Results

In cohort 1, the mean 1‐h CCI was 14.3 ± 6.9, and the 24‐h CCI was 8.7 ± 5.6. In cohort 2, the 1‐h CCI was 11.6 ± 7.8 and the 24‐h CCI was 7.0 ± 6.1. In the control group, the 1‐h CCI was 15.4 ± 5.5 and 24‐h CCI 8.7 ± 4.8. Bleeding complications of WHO grade ≥2 occurred in 40% of patients in cohort 1 compared to 44% in plasma PCs. The incidence of adverse reactions was 1.2% in the two PAS‐E cohorts, compared to 3.0% in plasma PCs. National hemovigilance data showed a significant reduction in allergic reactions with PAS‐E PC transfusions as compared to plasma PCs with an odds ratio of 0.46 (CI 95% 0.37–0.58).

Conclusion

The CCIs of PLTs in PAS‐E were decreased compared to plasma PCs, but clinically acceptable. Allergic transfusion reactions were decreased in PAS‐E PCs compared to plasma PCs.

Subjects

MeSH terms (MEDLINE)

Transfusion ReactionHypersensitivityHumansBlood PlateletsPlatelet TransfusionBlood SafetyBlood Preservation

Author keywords

adverse reactionbleeding scoreplatelet additive solutionplatelet concentrateplatelet increment

Authors and institutions

  • Department of Transfusion Medicine, Sanquin Blood Bank, Amsterdam, The Netherlands.
  • Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands.
  • Department of Product and Process Development, Sanquin Blood Bank, Amsterdam, The Netherlands.
  • Department of Laboratory Medicine, Amphia Hospital, Breda, The Netherlands.
  • TRIP (Transfusion and Transplantation Reactions in Patients) Hemovigilance and Biovigilance Office, Leiden, The Netherlands.

ORCID profiles: Saskia E Spelmink, Leo van de Watering, Adriaan J van Gammeren

Funding

  • Terumo BCT

Cite

APA

Spelmink, S. E., Jager, S. T., van de Watering, L., van der Meer, P. F., van Gammeren, A. J., Wiersum-Osselton, J. C., Klei, T. R. L., Kerkhoffs, J. H., & PAS-E Research group (2023). Efficacy and safety of platelet additive solution‐E stored platelet concentrates. Transfusion. https://doi.org/10.1111/trf.17583

Vancouver

Spelmink SE, Jager ST, van de Watering L, van der Meer PF, van Gammeren AJ, Wiersum-Osselton JC, et al. Efficacy and safety of platelet additive solution‐E stored platelet concentrates. Transfusion. 2023. doi:10.1111/trf.17583

BibTeX
@article{Spelmink2023,
  author = {Spelmink, Saskia E and Jager, Suzanne T and van de Watering, Leo and van der Meer, Pieter F and van Gammeren, Adriaan J and Wiersum-Osselton, Johanna C and Klei, Thomas R L and Kerkhoffs, Jean-Louis H and PAS-E Research group, PAS-E Research group},
  title = {Efficacy and safety of platelet additive solution‐E stored platelet concentrates},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17583}
}
Start for free →